Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?
Moreau
Emilie
E
André
Nicolas
N
Coze
Carole
C
Padovani
Laetitia
L
Mercier
Cedric
C
Ciccolini
Joseph
J
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002675:Child, Preschool; D003564:Cytidine Deaminase / Q000172:deficiency*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D009447:Neuroblastoma / Q000188:drug therapy*; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D003564:Cytidine Deaminase; D000093542:Gemcitabine